CCA
Cravens & Co Advisors Portfolio holdings
AUM
$146M
1-Year Est. Return
16.44%
1 Year Est. Return
+16.44%
AUM
$134M
AUM Growth
+$5.29M
(+4.1%)
Holding
59
Top Buys
| 1 | +$1.2M | |
| 2 | +$827K | |
| 3 | +$454K | |
| 4 |
Illumina
ILMN
|
+$351K |
| 5 |
Dimensional US Core Equity 2 ETF
DFAC
|
+$299K |
Top Sells
| 1 | +$5.41M | |
| 2 | +$1.02M | |
| 3 | +$816K | |
| 4 |
Rio Tinto
RIO
|
+$723K |
| 5 |
Cenovus Energy
CVE
|
+$276K |
Sector Composition
| 1 | Financials | 10.45% |
| 2 | Technology | 7.29% |
| 3 | Communication Services | 4.56% |
| 4 | Consumer Discretionary | 3.99% |
| 5 | Healthcare | 3.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Crown Castle
CCI
$39B
| $232K | 0.17% |
2,257
+34
|
|
||
52
Capital Group Global Growth Equity ETF
CGGO
$7.32B
| $200K | 0.15% |
6,271
-806
|
|
||
53
Vale
VALE
$51.9B
| $199K | 0.15% |
20,530
+376
|
|
||
54
Prospect Capital
PSEC
$1.27B
| $63.6K | 0.05% |
20,000
|
|
||
55
AdvisorShares Pure US Cannabis ETF
MSOS
$747M
| $40.9K | 0.03% |
16,968
+1,780
|
|
||
56
AbbVie
ABBV
$387B
| – | – |
-4,866
|
|
||
|
57
Cenovus Energy
CVE
$30.5B
| – | – |
-19,808
|
|
||
58
Regeneron Pharmaceuticals
REGN
$69.1B
| – | – |
-1,286
|
|
||
|
59
Rio Tinto
RIO
$113B
| – | – |
-12,040
|
|